MedPath

Incorporating Ecological Momentary Assessment and Personalized Telephone Support Into Group-Based Exercise Intervention for Depressive Symptoms

Not Applicable
Recruiting
Conditions
Depression
Interventions
Behavioral: Group-based exercise intervention with EMA and personalized telephone support (SUP)
Behavioral: Group-based exercise intervention (EXE)
Registration Number
NCT05704504
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

The objective of this proposed pilot randomized controlled trial is to examine the efficacy and acceptability of using smartphone-delivered ecological momentary assessment (EMA) and personalized telephone support to promote adherence to a 6-week group-based exercise intervention for improving depressive symptoms.

Prior to all study procedures, eligible participants are required to complete an online informed consent via an in-house smartphone application, Longitudinax Pro. Around 60 eligible participants aged 18-65 years old with Patient Health Questionnaire (PHQ-9) total score ≥10 (Kroenke et al., 2001) and International Physical Activity Questionnaire (IPAQ) total score \<600 MET/week (Lai et al., 2018; Macfarlane et al., 2007) will be randomly assigned to either 1) group-based exercise intervention with EMA and personalized telephone support (SUP), 2) group-based exercise intervention (EXE), or no intervention control group (CON) in a ratio of 1:1:1. The randomization will be performed by an independent assessor using a computer-generated list of numbers. The SUP and EXE groups will participate in a 6-week group-based exercise intervention. The intervention includes three biweekly group-based exercise sessions lasting for 120 minutes each (i.e., Week 1, 3, and 5). In addition, participants in the SUP will receive daily smartphone-delivered EMAs throughout the intervention period (i.e., 6-week) and 15-minute personalized telephone support delivered by a research personnel in Week 2, 4, and 6, respectively. Participants in the CON group will not be given any intervention during the study period but will be advised to remain their typical lifestyle throughout the trial period. The primary outcome of interest include depressive symptoms as measured by PHQ-9. The secondary outcomes will include anxiety symptoms, perceived insomnia severity, quality of life, functional impairment, and intervention evaluation at immediate post-intervention (Week 7) and 3-month follow-up assessments (Week 19).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. Hong Kong residents
  2. Aged ≥ 18 years
  3. Able to read Chinese and type in Chinese or English
  4. Have a Patient Health Questionnaire-9(PHQ-9) item score ≥10 indicating at least moderate level of depressive symptoms
  5. Have an International Physical Activities Questionnaire- Chinese version (IPAQ-C) score <600 MET indicating physically inactive.
  6. Have an Internet-enabled mobile device (iOS or Android operating system)
  7. Willing to provide informed consent and comply with the trial protocol
Read More
Exclusion Criteria
  1. Received psychotherapy for depression in the past 6 months
  2. A change in psychotropic drugs that target depression within 2 weeks before the baseline assessment
  3. A PHQ-9 question 9 score higher than 2, indicating a moderate level of suicidal risk that requires active crisis management (referral information to professional mental health services will be provided)
  4. Currently participating in another interventional study that may potentially improve mental health
  5. Pregnancy
  6. Self-disclosure of any psychiatric,medical or neurocognitive disorder(s) that makes participation unsuitable based on the team's clinical experience or interferes with adherence to the lifestyle modification (e.g., where exercise is not recommended by physicians)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group-based exercise intervention with EMA and personalized telephone support (SUP)Group-based exercise intervention with EMA and personalized telephone support (SUP)Participants in the SUP group will receive a 6-week group-based exercise intervention with ecological momentary assessment (EMA)and personalized telephone support.
Group-based exercise intervention (EXE)Group-based exercise intervention (EXE)Participants in the EXE group will receive a 6-week group-based exercise intervention.
Primary Outcome Measures
NameTimeMethod
Change in the Patient Health Questionnaire (PHQ-9)Baseline, immediate post-intervention, and 3-month follow-up

The PHQ-9, a 9-item questionnaire used for screening, diagnosing, monitoring, and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day).

Secondary Outcome Measures
NameTimeMethod
Change in the Insomnia Severity Index (ISI)Baseline, immediate post-intervention, and 3-month follow-up

ISI is a 7-item scale designed to evaluate perceived insomnia severity. Ratings on the 5-point Likert scale are obtained on the perceived severity of sleep-onset, sleep-maintenance, early morning awakening problems, satisfaction with current sleep pattern, interference with daily functioning, noticeably of impairment attributed to the sleep problem, and level of distress caused by the sleep problem.

Change in the Treatment Acceptability and Adherence Scale (TAAS)Baseline and immediate post-intervention

TAAS is a self-reported, ten-item questionnaire that is rated by a seven-point Likert scale from 1 to 7, and it aims at evaluating the clients' attitude toward the treatment sessions by four domains, including acceptability, adherence, drop-out, and distress.

Change in the Generalized Anxiety Disorder 7-item Scale (GAD-7)Baseline, immediate post-intervention, and 3-month follow-up

A brief 7-item instrument for screening for GAD and assessing its severity in clinical practice and research. Anxiety severity is categorized using scores of 5-9 (mild), 10-14 (moderate) and 15 or more (severe).

Change in the Short Form (Six-Dimension) Health Survey - The Chinese (Hong Kong) VersionBaseline, immediate post-intervention, and 3-month follow-up

A preference-based single index measure of health. A six-digit number represents each SF-6D health state, each digit denotes the level of one of six SF-6D dimensions: physical functioning, role limitation, social functioning, bodily pain, mental health, and vitality. The SF-6D index, scored from 0.0 (worst health state) to 1.0 (best health state).

Change in the Sheehan Disability Scale (SDS)Baseline, immediate post-intervention, and 3-month follow-up

SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.

Change in the International Physical Activities Questionnaire - Chinese version (IPAQ-C)Baseline, immediate post-intervention, and 3-month follow-up

Participants' sitting time, walking time and moderate and vigorous physical activity are assessed by 5 questions from a short form of the International Physical Activity Questionnaire - Chinese version a short form of the IPAQ-C.

Change in the Short Multidimensional Inventory Lifestyle Evaluation (SMILE)Baseline, immediate post-intervention, and 3-month follow-up

The SMILE is a 43-item self-report questionnaire designed to measure 7 aspects of lifestyle, which included diet and nutrition (7-item), substance use (4-item), exercise (3-item), stress management (10-item), sleep management (5- item), social support (10-item), and environmental exposures (4-item). Each item is rated on a 4-point Likert scale. The possible response categories of each item are always (4), several days (3), seldom (2), and never (1).

Change in Credibility-Expectancy Questionnaire (CEQ)Baseline and immediate post-intervention

The 6-item CEQ yielded ratings of treatment credibility, acceptability/satisfaction, and expectations for success. Specific wording referencing "anxiety" was changed to refer to "depression".

Trial Locations

Locations (1)

The Chinese University of Hong Kong

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath